About NEOMATIS PHARMA PRIVATE LIMITED
NEOMATIS PHARMA PRIVATE LIMITED is a Private Limited Company and was incorporated on Jul 12, 2021 in India. It is registered at Registrar of Companies, ROC Gwalior. Its registered address is 203 Fortune Ambience, 4/2 South Tukoganj, Indore Tukoganj, Indore, Indore, Madhya Pradesh, India, 452001. Its corporate identification number is (CIN) U24100MP2021PTC056653 and its current status is Active. Its industry classification as per MCA is manufacture Of Basic Chemicals.
NEOMATIS PHARMA PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2025 as per records from Ministry of Corporate Affairs (MCA). NEOMATIS PHARMA PRIVATE LIMITED's authorised share capital is ₹15L and its paid up capital is ₹15L. The current board of directors of NEOMATIS PHARMA PRIVATE LIMITED comprises Sanjeev Purviya, Ramakant Yaduvanshi and 1 more.
NEOMATIS PHARMA PRIVATE LIMITED generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2025.
Contact Details for NEOMATIS PHARMA PRIVATE LIMITED
- *****@gmail.com
- Registered Address
- 203 Fortune Ambience, 4/2 South Tukoganj, Indore Tukoganj, Indore, Indore, Madhya Pradesh, India, 452001
Principal Business Activity of NEOMATIS PHARMA PRIVATE LIMITED
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | xcv |
Documents of NEOMATIS PHARMA PRIVATE LIMITED
Financials of NEOMATIS PHARMA PRIVATE LIMITEDFY 25 Available
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
Income Statement | ||||
Revenue | 4264 | 3248 | 7226 | 9216 |
EBITDA | 7444 | 9023 | 1569 | 9012 |
Balance Sheet | ||||
Assets | 6918 | 2723 | 6448 | 2889 |
Liabilities | 1421 | 5118 | 6363 | 9126 |
Equities | 6129 | 6363 | 2362 | 4985 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
Profitability Ratios | ||||
EBITDA Margin | 8009 | 4455 | 4948 | 8236 |
Efficiency Ratios | ||||
Asset Turnover | 6917 | 8806 | 3305 | 5916 |
Liquidity Ratios | ||||
Current Ratio | 5214 | 4703 | 3315 | 7436 |
Quick Ratio | 2302 | 9830 | 4807 | 5789 |
Growth Ratios | ||||
Revenue Growth Rate (CAGR) | 4401 | 8227 | 2833 | 5772 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of NEOMATIS PHARMA PRIVATE LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | 112% |
3 Year | 794 |
5 Year | 861 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 58% |
3 Year | 568 |
5 Year | 325 |
MSME Payment Delays by NEOMATIS PHARMA PRIVATE LIMITED
Credit Ratings of NEOMATIS PHARMA PRIVATE LIMITED
GSTIN Details of NEOMATIS PHARMA PRIVATE LIMITED
Board of Directors and Signatories of NEOMATIS PHARMA PRIVATE LIMITED
Board of Directors of NEOMATIS PHARMA PRIVATE LIMITED
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Jul 12, 2021 | 4 Years 11 Months | |
Director | Current | Feb 03, 2022 | 4 Years 5 Months | |
Director | Current | Jan 24, 2024 | 2 Years 5 Months |
Signatories of NEOMATIS PHARMA PRIVATE LIMITED
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Jul 12, 2021 | 4 Years 11 Months | |
Director | Current | Feb 03, 2022 | 4 Years 5 Months | |
Director | Current | Jan 24, 2024 | 2 Years 5 Months |